Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/39080
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWiendl, H.-
dc.contributor.authorBenedict, R. H.-
dc.contributor.authorComi, G.-
dc.contributor.authorOreja-Guevara, C.-
dc.contributor.authorSiva, A.-
dc.contributor.authorVAN WIJMEERSCH, Bart-
dc.contributor.authorBuffels, R.-
dc.contributor.authorKuenzel, T.-
dc.contributor.authorVermersch, P.-
dc.date.accessioned2022-12-19T11:59:06Z-
dc.date.available2022-12-19T11:59:06Z-
dc.date.issued2022-
dc.date.submitted2022-12-09T14:12:32Z-
dc.identifier.citationMultiple Sclerosis Journal, 28 (S3) (Art. P776)-
dc.identifier.urihttp://hdl.handle.net/1942/39080-
dc.description.sponsorshipWe would like to thank all patients, their families and the investigators participating in this study. This study was sponsored by F. Hoffmann-La Roche Ltd, Basel, Switzerland. Writing and editorial assistance for this presentation was provided by Articulate Science, UK, and funded by F. Hoffmann-La Roche Ltd, Basel, Switzerland.-
dc.language.isoen-
dc.publisherSAGE PUBLICATIONS LTD-
dc.titleEmployment and cognitive improvements in ocrelizumab-treated patients with relapsing-remitting multiple sclerosis: 96-week CASTING study data-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateOCT 26-28, 2022-
local.bibliographicCitation.conferencename38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis-
local.bibliographicCitation.conferenceplaceAmsterdam, NETHERLANDS-
dc.identifier.issueS3-
dc.identifier.volume28-
local.format.pages2-
local.bibliographicCitation.jcatM-
local.publisher.place1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
local.bibliographicCitation.artnrP776-
dc.identifier.isi000866540802370-
local.provider.typewosris-
local.description.affiliation[Wiendl, H.] Univ Munster, Dept Neurol, Inst Translat Neurol, Munster, Germany.-
local.description.affiliation[Benedict, R. H.] SUNY Buffalo, Dept Neurol, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA.-
local.description.affiliation[Comi, G.] Univ Vita Salute San Raffaele, Milan, Italy.-
local.description.affiliation[Comi, G.] Casa Cura Policlin, Milan, Italy.-
local.description.affiliation[Oreja-Guevara, C.] Hosp Clin San Carlos, Madrid, Spain.-
local.description.affiliation[Siva, A.] Istanbul Univ, Cerrahpasa Med Sch, Istanbul, Turkey.-
local.description.affiliation[Van Wijmeersch, B.] Hasselt Univ, Univ MS Ctr, Hasselt, Belgium.-
local.description.affiliation[Buffels, R.; Kuenzel, T.] F Hoffmann La Roche Ltd, Basel, Switzerland.-
local.description.affiliation[Vermersch, P.] Univ Lille, CHU Lille, Inserm U1172, LilNCog,FHU Precise, Lille, France.-
local.uhasselt.internationalyes-
item.contributorWiendl, H.-
item.contributorBenedict, R. H.-
item.contributorComi, G.-
item.contributorOreja-Guevara, C.-
item.contributorSiva, A.-
item.contributorVAN WIJMEERSCH, Bart-
item.contributorBuffels, R.-
item.contributorKuenzel, T.-
item.contributorVermersch, P.-
item.accessRightsOpen Access-
item.fullcitationWiendl, H.; Benedict, R. H.; Comi, G.; Oreja-Guevara, C.; Siva, A.; VAN WIJMEERSCH, Bart; Buffels, R.; Kuenzel, T. & Vermersch, P. (2022) Employment and cognitive improvements in ocrelizumab-treated patients with relapsing-remitting multiple sclerosis: 96-week CASTING study data. In: Multiple Sclerosis Journal, 28 (S3) (Art. P776).-
item.fulltextWith Fulltext-
crisitem.journal.issn1352-4585-
crisitem.journal.eissn1477-0970-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Employment and cognitive improvements in ocrelizumab-treated.pdfPublished version73.32 kBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.